American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 259-263 , August 2010

Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?

  • Lance D. Dworkin, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Lance D. Dworkin, MD, Department of Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903
    • ,
  • Timothy Murphy, MD

References 

  1. Simon G. What is critical renal artery stenosis? (Implications for treatment). Am J Hypertens. 2000;13(11):1189–1193
  2. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in the United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293–301
  3. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443–451
  4. Suresh M, Laboi P, Mamtora H, Kalra PA. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2000;15(5):631–636
  5. Conlon PJ, Little MA, Piper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60(4):1490–1497
  6. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53(3):735–742
  7. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis (Dutch Renal Artery Stenosis Intervention Cooperative Study Group). N Engl J Med. 2000;342(14):1007–1014
  8. Chabova V, Schirger A, Stanson AW, McKusick MA, Textor SC. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75(5):437–444
  9. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19(2):250–257discussion, 257-258
  10. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98(7):642–647
  11. Wahlander H, Isgaard J, Jennische E, Friberg P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension. 1992;19(1):25–32
  12. Losito A, Fagugli RM, Zampi I, et al. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens. 1996;9(11):1062–1067
  13. de Simone G, Devereux RB, Camargo MJ, et al. In vivo left ventricular anatomy in rats with two-kidney, one clip and one-kidney, one clip renovascular hypertension. J Hypertens. 1992;10(8):725–732
  14. Gavras H, Lever AF, Brown JJ, Macadam RF, Robertson JI. Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet. 1971;2(7714):19–22
  15. Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction. J Hypertens Suppl. 1994;12(10):S153–S157
  16. Hocher B, George I, Rebstock J, et al. Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension. 1999;33(3):816–822
  17. Robertson AL, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science. 1971;172(988):1138–1139
  18. Ehmke H, Faulhaber J, Munter K, Kirchengast M, Wiesner RJ. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats. Hypertension. 1999;33(4):954–960
  19. Cohen MG, Pascua JA, Garcia-Ben M, et al. A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J. 2005;150(6):1204–1211
  20. Roberts JC, Wilkins RH, Moses C. Autopsy studies in atherosclerosis (II. Distribution and severity of atherosclerosis in patients dying with morphologic evidence of atherosclerotic catastrophe). Circulation. 1959;20:520–526
  21. Rossi GP, Rossi A, Zanin L. Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertens. 1992;5(1):8–15
  22. Horvath JS, Waugh RC, Tiller DJ, Duggin GG. The detection of renovascular hypertension: a study of 490 patients by renal angiography. Q J Med. 1982;51(202):139–146
  23. Iglesias JI, Hamburger RJ, Feldman L, Kaufman JS. The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. Am J Med. 2000;109(8):642–647
  24. Uzu T, Inoue T, Fujii T, et al. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis. 1997;29(5):733–738
  25. Missouris CG, Belli AM, MacGregor GA. “Apparent” heart failure: a syndrome caused by renal artery stenoses. Heart. 2000;83(2):152–155
  26. Korner PI. Cardiovascular hypertrophy and hypertension: causes and consequences. Blood Press Suppl. 1995;2:6–16
  27. ASTRAL Investigators. Revascularization versus medical therapy for renal artery stenosis. N Engl J Med. 2009;361(20):1953–1962
  28. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141–145
  29. Freedman B, Glass KC, Weijer C. Placebo orthodoxy in clinical research (II: ethical, legal, and regulatory myths). J Law Med Ethics. 1996;24(3):252–259
  30. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthén L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993;18(5):841–850discussion, 850-852
  31. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353(9149):282–286
  32. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis (Scottish and Newcastle Renal Artery Stenosis Collaborative Group). J Hum Hypertens. 1998;12(5):329–335
  33. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840–848W150-151
  34. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? (A meta-analysis of randomized controlled trials). Am J Med. 2003;114(1):44–50
  35. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. AJR Am J Roentgenol. 2004;183(3):561–568
  36. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145(12):901–912

 Originally published online as doi:10.1053/j.ajkd.2010.04.005 on June 28, 2010.

PII: S0272-6386(10)00726-2

doi: 10.1053/j.ajkd.2010.04.005

American Journal of Kidney Diseases
Volume 56, Issue 2 , Pages 259-263 , August 2010

Article Tools

* Image Usage & Resolution